Authorizes coverage of prescriptive hormone replacement therapy.
This New Jersey bill requires private health plans, state-purchased insurance contracts, and Medicaid to cover a 12-month supply of prescription hormone replacement therapy for individuals who do not need refrigeration. The legislation defines these drugs as FDA-approved medications used to regulate hormone levels but explicitly excludes certain weight-loss drugs. While the law mandates this coverage, it allows for specific exceptions, such as limiting refills during the last quarter of a plan year if a full supply was already provided, or temporarily reducing supplies to 90 days during acute drug shortages. Additionally, insurance providers retain the ability to use standard drug management strategies to oversee how these medications are prescribed and dispensed.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
Governor
Introduced May 11, 2026
Last action May 11, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
May 11, 2026
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Raj Mukherji
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4201
Scope: NJ
Hi! I can help you understand S 4201. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline